What is SXTC stock price today?

SXTC (China Sxt Pharmaceuticals Inc) stock is trading at $1.93 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is SXTC stock going up or down today?

SXTC stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy SXTC stock now?

The decision to buy SXTC depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is SXTC a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for SXTC based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is SXTC stock overvalued or undervalued?

Use our DCF valuation calculator to determine if SXTC is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is SXTC's P/E ratio?

P/E ratio data for SXTC will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is SXTC's market cap?

SXTC (China Sxt Pharmaceuticals Inc) has a market capitalization of $0.00 billion, making it a small-cap stock.

What is SXTC's price to book ratio?

SXTC trades at a price-to-book (P/B) ratio of 0.09, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does SXTC pay dividends?

SXTC does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is SXTC's dividend yield?

SXTC does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is SXTC stock a good long-term investment?

SXTC's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is SXTC's revenue growth rate?

SXTC has shown revenue growth of -0.2% over recent periods. Consistent revenue growth is a key indicator of business health and competitive positioning.

Profitability metrics for SXTC are available on our dashboard with complete income statement analysis.

What are the risks of investing in SXTC?

Key risks for SXTC include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does SXTC compare to its competitors?

Compare SXTC to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize SXTC's performance and positioning.

What is SXTC's stock price target for 2026?

Our AI model provides price targets for SXTC based on fundamental analysis: Bull case $2.51 (+30%), Base case $2.22 (+15%), Bear case $1.73 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about SXTC?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for SXTC. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is SXTC's next earnings report?

SXTC reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

SXTC - China Sxt Pharmaceuticals Inc

NYSE * Health Care * Pharmaceuticals

$1.93

+$0.07 (+3.62%)

About China Sxt Pharmaceuticals Inc

China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, ShaRen, and ChenXiang. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company serves pharmaceutical companies, chain pharmacies, and hospitals, as well as pharmaceutical distributors. China SXT Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Taizhou, China.

SXTC Key Statistics

Market Cap

$1.78M

P/B Ratio

0.09

EPS

$-57.15

Revenue Growth

-0.2%

Employees

How SXTC Compares to Peers

SXTC is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 1

Margin Rank

N/A

of 1

Growth Rank

of 2

Size Rank

of 2

Company	Market Cap	P/E	Growth	Margin	Compare
SXTC(This stock)	$1.78M	N/A	-0%	0.0%	-
AMZNAmazon Com	$2.69T	34.9	0%	0.1%	vs AMZN

China Sxt Pharmaceuticals Inc Company Information

Headquarters: China
Website: www.sxtchina.com
Sector: Health Care
Industry: Pharmaceuticals

Data Updated: April 19, 2026 at 12:49 AM EDT

Ready to invest in SXTC?

Commission-free trading available. Affiliate links.

Upcoming Events for SXTC

Dashboard

Enter a ticker to analyze